Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 142

1.

Differences in bingeing behavior and cocaine reward following intermittent access to sucrose, glucose or fructose solutions.

Rorabaugh JM, Stratford JM, Zahniser NR.

Neuroscience. 2015 Aug 20;301:213-20. doi: 10.1016/j.neuroscience.2015.06.015. Epub 2015 Jun 14.

2.

Escalation of cocaine consumption in short and long access self-administration procedures.

Mandt BH, Copenhagen LI, Zahniser NR, Allen RM.

Drug Alcohol Depend. 2015 Apr 1;149:166-72. doi: 10.1016/j.drugalcdep.2015.01.039. Epub 2015 Feb 9.

3.

DAT isn't all that: cocaine reward and reinforcement require Toll-like receptor 4 signaling.

Northcutt AL, Hutchinson MR, Wang X, Baratta MV, Hiranita T, Cochran TA, Pomrenze MB, Galer EL, Kopajtic TA, Li CM, Amat J, Larson G, Cooper DC, Huang Y, O'Neill CE, Yin H, Zahniser NR, Katz JL, Rice KC, Maier SF, Bachtell RK, Watkins LR.

Mol Psychiatry. 2015 Dec;20(12):1525-37. doi: 10.1038/mp.2014.177. Epub 2015 Feb 3.

4.

Teaching corporate in college.

Valantine HA, Beckerle MC, Reed KL, Towner D, Zahniser NR.

Sci Transl Med. 2014 Aug 27;6(251):251fs33. doi: 10.1126/scitranslmed.3009450.

PMID:
25163476
5.

A relationship between reduced nucleus accumbens shell and enhanced lateral hypothalamic orexin neuronal activation in long-term fructose bingeing behavior.

Rorabaugh JM, Stratford JM, Zahniser NR.

PLoS One. 2014 Apr 15;9(4):e95019. doi: 10.1371/journal.pone.0095019. eCollection 2014.

6.

Low- and high-cocaine locomotor responding rats differ in reinstatement of cocaine seeking and striatal mGluR5 protein expression.

Simmons DL, Mandt BH, Ng CM, Richards TL, Yamamoto DJ, Zahniser NR, Allen RM.

Neuropharmacology. 2013 Dec;75:347-55. doi: 10.1016/j.neuropharm.2013.08.001. Epub 2013 Aug 22.

7.

Rats classified as low or high cocaine locomotor responders: a unique model involving striatal dopamine transporters that predicts cocaine addiction-like behaviors.

Yamamoto DJ, Nelson AM, Mandt BH, Larson GA, Rorabaugh JM, Ng CM, Barcomb KM, Richards TL, Allen RM, Zahniser NR.

Neurosci Biobehav Rev. 2013 Sep;37(8):1738-53. doi: 10.1016/j.neubiorev.2013.07.002. Epub 2013 Jul 12. Review.

8.
9.

Differences in rat dorsal striatal NMDA and AMPA receptors following acute and repeated cocaine-induced locomotor activation.

Yamamoto DJ, Zahniser NR.

PLoS One. 2012;7(5):e37673. doi: 10.1371/journal.pone.0037673. Epub 2012 May 24.

10.

Cocaine dose and self-administration history, but not initial cocaine locomotor responsiveness, affects sensitization to the motivational effects of cocaine in rats.

Mandt BH, Gomez E, Johnston NL, Zahniser NR, Allen RM.

J Pharmacol Exp Ther. 2012 Jul;342(1):214-21. doi: 10.1124/jpet.112.194092. Epub 2012 Apr 19.

11.

Epitope-tagged dopamine transporter knock-in mice reveal rapid endocytic trafficking and filopodia targeting of the transporter in dopaminergic axons.

Rao A, Richards TL, Simmons D, Zahniser NR, Sorkin A.

FASEB J. 2012 May;26(5):1921-33. doi: 10.1096/fj.11-196113. Epub 2012 Jan 20.

12.

Direct reprogramming of human fibroblasts into dopaminergic neuron-like cells.

Liu X, Li F, Stubblefield EA, Blanchard B, Richards TL, Larson GA, He Y, Huang Q, Tan AC, Zhang D, Benke TA, Sladek JR, Zahniser NR, Li CY.

Cell Res. 2012 Feb;22(2):321-32. doi: 10.1038/cr.2011.181. Epub 2011 Nov 22.

13.

Medical faculty development: a modern-day odyssey.

Beckerle MC, Reed KL, Scott RP, Shafer MA, Towner D, Valantine HA, Zahniser NR.

Sci Transl Med. 2011 Oct 12;3(104):104cm31. doi: 10.1126/scitranslmed.3002763.

PMID:
21998405
14.

Attention-deficit/hyperactivity disorder: is it time to reappraise the role of sugar consumption?

Johnson RJ, Gold MS, Johnson DR, Ishimoto T, Lanaspa MA, Zahniser NR, Avena NM.

Postgrad Med. 2011 Sep;123(5):39-49. doi: 10.3810/pgm.2011.09.2458. Review.

15.

Acquisition of cocaine self-administration in male Sprague-Dawley rats: effects of cocaine dose but not initial locomotor response to cocaine.

Mandt BH, Johnston NL, Zahniser NR, Allen RM.

Psychopharmacology (Berl). 2012 Feb;219(4):1089-97. doi: 10.1007/s00213-011-2438-6. Epub 2011 Aug 24. Erratum in: Psychopharmacology (Berl).2012 Jun;221(3):539. Dosage error in article text.

16.

Dopamine transport by the serotonin transporter: a mechanistically distinct mode of substrate translocation.

Larsen MB, Sonders MS, Mortensen OV, Larson GA, Zahniser NR, Amara SG.

J Neurosci. 2011 Apr 27;31(17):6605-15. doi: 10.1523/JNEUROSCI.0576-11.2011.

17.

Using High-Speed Chronoamperometry with Local Dopamine Application to Assess Dopamine Transporter Function.

Gulley JM, Larson GA, Zahniser NR.

In: Michael AC, Borland LM, editors. Electrochemical Methods for Neuroscience. Boca Raton (FL): CRC Press/Taylor & Francis; 2007. Chapter 6.

18.

Neurotransplantation of stem cells genetically modified to express human dopamine transporter reduces alcohol consumption.

Grammatopoulos TN, Jones SM, Yoshimura M, Hoover BR, Das M, Snyder EY, Larson GA, Zahniser NR, Tabakoff B, Zawada WM.

Stem Cell Res Ther. 2010 Dec 1;1(5):36. doi: 10.1186/scrt36.

19.

Individual differences in cocaine-induced locomotor activity of male Sprague-Dawley rats are not explained by plasma corticosterone levels.

Nelson AM, Kleschen MJ, Zahniser NR.

Neurosci Lett. 2010 May 26;476(1):9-13. doi: 10.1016/j.neulet.2010.03.032. Epub 2010 Mar 17.

20.

Low and high cocaine locomotor responding male Sprague-Dawley rats differ in rapid cocaine-induced regulation of striatal dopamine transporter function.

Mandt BH, Zahniser NR.

Neuropharmacology. 2010 Mar;58(3):605-12. doi: 10.1016/j.neuropharm.2009.11.015. Epub 2009 Dec 4.

21.

Low or high cocaine responding rats differ in striatal extracellular dopamine levels and dopamine transporter number.

Nelson AM, Larson GA, Zahniser NR.

J Pharmacol Exp Ther. 2009 Dec;331(3):985-97. doi: 10.1124/jpet.109.159897. Epub 2009 Sep 3.

22.

Cyclin-dependent kinase 5 inhibitors: inhibition of dopamine transporter activity.

Price DA, Sorkin A, Zahniser NR.

Mol Pharmacol. 2009 Oct;76(4):812-23. doi: 10.1124/mol.109.056978. Epub 2009 Jul 23.

23.

Trafficking of dopamine transporters in psychostimulant actions.

Zahniser NR, Sorkin A.

Semin Cell Dev Biol. 2009 Jun;20(4):411-7. doi: 10.1016/j.semcdb.2009.01.004. Epub 2009 Jan 22. Review.

24.

Negative regulation of dopamine transporter endocytosis by membrane-proximal N-terminal residues.

Sorkina T, Richards TL, Rao A, Zahniser NR, Sorkin A.

J Neurosci. 2009 Feb 4;29(5):1361-74. doi: 10.1523/JNEUROSCI.3250-08.2009.

25.

Rapid substrate-induced down-regulation in function and surface localization of dopamine transporters: rat dorsal striatum versus nucleus accumbens.

Richards TL, Zahniser NR.

J Neurochem. 2009 Mar;108(6):1575-84. doi: 10.1111/j.1471-4159.2009.05910.x. Epub 2009 Jan 22.

26.

Amphetamine and methamphetamine differentially affect dopamine transporters in vitro and in vivo.

Goodwin JS, Larson GA, Swant J, Sen N, Javitch JA, Zahniser NR, De Felice LJ, Khoshbouei H.

J Biol Chem. 2009 Jan 30;284(5):2978-89. doi: 10.1074/jbc.M805298200. Epub 2008 Dec 1.

27.

Individual differences in initial low-dose cocaine-induced locomotor activity and locomotor sensitization in adult outbred female Sprague-Dawley rats.

Mandt BH, Allen RM, Zahniser NR.

Pharmacol Biochem Behav. 2009 Feb;91(4):511-6. doi: 10.1016/j.pbb.2008.09.002. Epub 2008 Sep 10.

28.

Administration of ziprasidone for 10 days increases cocaine toxicity in mice.

Heard K, Krier S, Zahniser NR.

Hum Exp Toxicol. 2008 Jun;27(6):499-503. doi: 10.1177/0960327108095471.

29.

Individual differences in cocaine-induced locomotor activity in male Sprague-Dawley rats and their acquisition of and motivation to self-administer cocaine.

Mandt BH, Schenk S, Zahniser NR, Allen RM.

Psychopharmacology (Berl). 2008 Dec;201(2):195-202. doi: 10.1007/s00213-008-1265-x. Epub 2008 Aug 7.

30.

Mechanisms of acute cocaine toxicity.

Heard K, Palmer R, Zahniser NR.

Open Pharmacol J. 2008;2(9):70-78.

31.

Rapid regulation of dopamine transporters by tyrosine kinases in rat neuronal preparations.

Hoover BR, Everett CV, Sorkin A, Zahniser NR.

J Neurochem. 2007 Jun;101(5):1258-71. Epub 2007 Apr 10.

32.
33.

Low and high locomotor responsiveness to cocaine predicts intravenous cocaine conditioned place preference in male Sprague-Dawley rats.

Allen RM, Everett CV, Nelson AM, Gulley JM, Zahniser NR.

Pharmacol Biochem Behav. 2007 Jan;86(1):37-44. Epub 2006 Dec 20.

34.

RNA interference screen reveals an essential role of Nedd4-2 in dopamine transporter ubiquitination and endocytosis.

Sorkina T, Miranda M, Dionne KR, Hoover BR, Zahniser NR, Sorkin A.

J Neurosci. 2006 Aug 2;26(31):8195-205.

35.

Confirmation and fine mapping of ethanol sensitivity quantitative trait loci, and candidate gene testing in the LXS recombinant inbred mice.

Bennett B, Carosone-Link P, Zahniser NR, Johnson TE.

J Pharmacol Exp Ther. 2006 Oct;319(1):299-307. Epub 2006 Jun 27.

PMID:
16803863
36.

Norepinephrine transporter: a candidate gene for initial ethanol sensitivity in inbred long-sleep and short-sleep mice.

Haughey HM, Kaiser AL, Johnson TE, Bennett B, Sikela JM, Zahniser NR.

Alcohol Clin Exp Res. 2005 Oct;29(10):1759-68.

PMID:
16269905
37.
38.

Differential regulation of cocaine-induced locomotor activity in inbred long-sleep and short-sleep mice by dopamine and serotonin systems.

Hanania T, McCreary AC, Salaz DO, Lyons AM, Zahniser NR.

Eur J Pharmacol. 2004 Oct 19;502(3):221-31.

PMID:
15476748
39.

Rapid regulation of the dopamine transporter: role in stimulant addiction?

Zahniser NR, Sorkin A.

Neuropharmacology. 2004;47 Suppl 1:80-91. Review.

PMID:
15464127
40.

Individual differences in cocaine- and amphetamine-induced activation of male Sprague-Dawley rats: contribution of the dopamine transporter.

Briegleb SK, Gulley JM, Hoover BR, Zahniser NR.

Neuropsychopharmacology. 2004 Dec;29(12):2168-79.

41.

Role of the dopamine transporter in the differential cocaine-induced locomotor activation of inbred long-sleep and short-sleep mice.

Hanania T, Gulley JM, Salaz DO, Larson GA, Zahniser NR.

Neuropsychopharmacology. 2004 Oct;29(10):1814-22.

42.

Rapid regulation of dopamine transporter function by substrates, blockers and presynaptic receptor ligands.

Gulley JM, Zahniser NR.

Eur J Pharmacol. 2003 Oct 31;479(1-3):139-52. Review.

PMID:
14612145
43.
44.
45.

Oligomerization of dopamine transporters visualized in living cells by fluorescence resonance energy transfer microscopy.

Sorkina T, Doolen S, Galperin E, Zahniser NR, Sorkin A.

J Biol Chem. 2003 Jul 25;278(30):28274-83. Epub 2003 May 13.

47.

MK-801- and ethanol-induced activity in inbred long-sleep and short-sleep mice: dopamine and serotonin systems.

Hanania T, McCreary AC, Haughey HM, Salaz DO, Zahniser NR.

Eur J Pharmacol. 2002 Dec 20;457(2-3):125-35.

PMID:
12464358
49.

Kinetic analysis of striatal clearance of exogenous dopamine recorded by chronoamperometry in freely-moving rats.

Sabeti J, Adams CE, Burmeister J, Gerhardt GA, Zahniser NR.

J Neurosci Methods. 2002 Nov 15;121(1):41-52.

PMID:
12393160
50.

Modulation of hippocampal glutamatergic transmission by ATP is dependent on adenosine a(1) receptors.

Masino SA, Diao L, Illes P, Zahniser NR, Larson GA, Johansson B, Fredholm BB, Dunwiddie TV.

J Pharmacol Exp Ther. 2002 Oct;303(1):356-63.

PMID:
12235271

Supplemental Content

Loading ...
Support Center